Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Mol Imaging Radionucl Ther ; 33(2): 121-124, 2024 Jun 28.
Article in English | MEDLINE | ID: mdl-38949492

ABSTRACT

Nowadays, the utility of positron emission tomography/computed tomography (PET/CT) is well established in nasopharyngeal carcinoma (NPC). The incidence of NPC in the West population, especially in children, is very low. We present the first Italian case of a pediatric patient with NPC followed up with 18F-fluorodeoxyglucose (18F-FDG) PET/CT scan in addition to the standard follow-up imaging methods, including CT and magnetic resonance imaging. The 18F-FDG PET/CT scan was helpful in discriminating between metastatic and benign osseous lesions, thereby helping clinicians to determine the most appropriate therapeutic regimen. These findings support the clinical utility of 18F-FDG PET/CT in the diagnostic work-up of pediatric patients with NPC.

2.
RMD Open ; 9(2)2023 05.
Article in English | MEDLINE | ID: mdl-37137540

ABSTRACT

OBJECTIVES: Aim of this study was to investigate the expression of interleukin (IL)-40, a new cytokine associated with B cells homoeostasis and immune response, in primary Sjögren syndrome (pSS) and in pSS-associated lymphomas. METHODS: 29 patients with pSS and 24 controls were enrolled. Minor salivary gland (MSG) biopsies from patients, controls and parotid gland biopsies from pSS-associated lymphoma were obtained. Quantitative gene expression analysis by TaqMan real-time PCR and immunohistochemistry for IL-40 were performed on MSG. MSG cellular sources of IL-40 were determined by flow-cytometry and immunofluorescence. Serum concentration of IL-40 was assessed by ELISA and cellular sources of IL-40 were determined by flow-cytometry. An in vitro assay with recombinant IL-40 (rIL-40) was performed to detect the effect on cytokine production from peripheral blood mononuclear cells (PBMCs). RESULTS: IL-40 was significantly increased in the lymphocytic infiltrated MSG of patients with pSS and correlated with focus score and with IL-4 and transforming growth factor-ß expression. In addition, IL-40 was increased in the serum of pSS and its levels correlated with the EULAR Sjögren's Syndrome Disease Activity Index score. B cells from patients were shown to be the major source of IL-40 at both tissue and peripheral level. PBMCs from patients, exposed to rIL-40 in vitro, released proinflammatory cytokines, specifically interferon-γ from B cells and T-CD8+ and tumour necrosis factor-α and IL-17 from both T-CD4+ and T-CD8+. IL-40 expression in parotid glands of pSS-associated lymphomas was also increased. Moreover, IL-40-driven NETosis was evidenced in neutrophils obtained from pSS. CONCLUSION: Our results suggest that IL-40 may play a role in pSS pathogenesis and pSS-associated lymphomas.


Subject(s)
Sjogren's Syndrome , Humans , Sjogren's Syndrome/metabolism , Leukocytes, Mononuclear/metabolism , Leukocytes, Mononuclear/pathology , Salivary Glands/metabolism , Interleukins/metabolism , Inflammation , Cytokines/metabolism
3.
Clin Exp Rheumatol ; 41(1): 94-102, 2023 01.
Article in English | MEDLINE | ID: mdl-35616583

ABSTRACT

OBJECTIVES: Interleukin 9 (IL-9) is a mediator of tissue damage in several inflammatory diseases. In this study we aimed to evaluate the effects of in vivo IL-9 neutralisation in mice developing collagen induced arthritis (CIA). METHODS: DBA/1 were immunised with collagen in Freund's complete adjuvant (CFA) to induce arthritis. Anti-IL-9 mAb was injected in mice after the onset of arthritis (Group A) or on the same day as sensitisation and again on the day of the challenge (Group B). Histological analysis was performed in joints of mice and spleen cells were also analysed by flow cytometry. A geneset analysis was carried out on whole tarsal joint tissue transcriptomes. RESULTS: IL-9 was over-expressed in swollen joints of mice developing arthritis. Treatment with anti-IL-9 mAb after arthritis onset efficiently down-modulated the severity of joint inflammation. Similarly, anti-IL-9 mAb administered on the same day as sensitisation and on the day of challenge also delayed the onset of arthritis. Anti-IL-9 mAb injection after the onset of arthritis was associated with a decrease of CD4+ TNF-α+ cells and an increase of CD4+ FoxP3+ IL-10+ cells. Geneset analysis in CIA showed an up-regulation of GATA3 with no significant direct interactions between IL-9 and GATA3, which instead was mediated by IL-5 through STAT6. CONCLUSIONS: Our results suggest that IL-9 is involved in the immunopathogenesis of CIA. Further implications for the clinical translation of our findings are discussed.


Subject(s)
Arthritis, Experimental , Animals , Mice , Arthritis, Experimental/pathology , Interleukin-9/therapeutic use , Mice, Inbred DBA , Disease Models, Animal , Tumor Necrosis Factor-alpha/therapeutic use
4.
Curr Med Res Opin ; 38(1): 139-143, 2022 01.
Article in English | MEDLINE | ID: mdl-34866503

ABSTRACT

In pediatric patients with Inflammatory Bowel Disease renal parenchymal disease is infrequent. There are only two reports about the association between IgA Nephropathy and Pediatric Crohn Disease. IgA Nephropathy is a rather uncommon complication of Tumor Necrosis Factor-alpha (TNF-α) inhibition. We describe a case of IgA Nephropathy which has arisen in a 11-year-old child 2 years after Crohn disease diagnosis, during therapy with anti-TNF-α. An ileal e jejunal Crohn disease was diagnosed at 9 years old, initially treated with prednisone, followed by biological therapy with anti-TNF-α (Adalimumab) due to severe disease activity, with gradual improvement of clinical conditions until clinical remission is achieved. Two years after the diagnosis, the child suddenly presented macroscopic hematuria. Subsequent laboratory examinations showed acute renal failure. So kidney biopsy was performed and IgA Nephropathy diagnosis was made. Adalimumab was discontinued and the child has been treated with steroids for sixth months associated with angiotensin-converting enzyme inhibitor resulted in clinical improvement over the following year and remission was maintained. To our knowledge the association of IgA Nephropathy and pediatric IBD during therapy with anti-TNF-α has never been reported. Careful monitoring of renal function, proteinuria, and autoantibodies is advised in patients treated with anti-TNF-α agents.


Subject(s)
Crohn Disease , Glomerulonephritis, IGA , Adalimumab/adverse effects , Child , Crohn Disease/complications , Crohn Disease/drug therapy , Glomerulonephritis, IGA/chemically induced , Glomerulonephritis, IGA/complications , Glomerulonephritis, IGA/drug therapy , Humans , Infliximab , Tumor Necrosis Factor Inhibitors , Tumor Necrosis Factor-alpha
6.
Nat Commun ; 12(1): 5006, 2021 08 18.
Article in English | MEDLINE | ID: mdl-34408135

ABSTRACT

Obesity is a strong risk factor for cancer progression, posing obesity-related cancer as one of the leading causes of death. Nevertheless, the molecular mechanisms that endow cancer cells with metastatic properties in patients affected by obesity remain unexplored.Here, we show that IL-6 and HGF, secreted by tumor neighboring visceral adipose stromal cells (V-ASCs), expand the metastatic colorectal (CR) cancer cell compartment (CD44v6 + ), which in turn secretes neurotrophins such as NGF and NT-3, and recruits adipose stem cells within tumor mass. Visceral adipose-derived factors promote vasculogenesis and the onset of metastatic dissemination by activation of STAT3, which inhibits miR-200a and enhances ZEB2 expression, effectively reprogramming CRC cells into a highly metastatic phenotype. Notably, obesity-associated tumor microenvironment provokes a transition in the transcriptomic expression profile of cells derived from the epithelial consensus molecular subtype (CMS2) CRC patients towards a mesenchymal subtype (CMS4). STAT3 pathway inhibition reduces ZEB2 expression and abrogates the metastatic growth sustained by adipose-released proteins. Together, our data suggest that targeting adipose factors in colorectal cancer patients with obesity may represent a therapeutic strategy for preventing metastatic disease.


Subject(s)
Adipose Tissue/cytology , Cellular Reprogramming , Colonic Neoplasms/physiopathology , Neoplastic Stem Cells/cytology , Stem Cell Niche , Adipose Tissue/metabolism , Animals , Colonic Neoplasms/genetics , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Hepatocyte Growth Factor/genetics , Hepatocyte Growth Factor/metabolism , Humans , Interleukin-6/genetics , Interleukin-6/metabolism , Male , Mice , Mice, SCID , MicroRNAs/genetics , MicroRNAs/metabolism , Neoplasm Metastasis , Stem Cells/cytology , Stem Cells/metabolism , Zinc Finger E-box Binding Homeobox 2/genetics , Zinc Finger E-box Binding Homeobox 2/metabolism
7.
Acta Histochem ; 123(6): 151771, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34419757

ABSTRACT

Tumors of the submandibular salivary gland (SMG) are uncommon but sufficiently frequent for the physician to consider them in routine examinations and for the pathologist to be prepared to differentiate them from other tissue abnormalities. However, scarcity of specimens makes training difficult, a situation compounded by the lack of accepted universal diagnostic guidelines. Furthermore, there is little information on the chaperone system (CS) of the gland, despite the increasing evidence of its participation in carcinogenesis as a biomarker for diagnosis and patient follow up, and in the mechanisms by which the tumor cells thrive. We are investigating this aspect of various tumors, and here we describe standardized methods for assessing the tissue levels of two chaperones, Hsp27 and Hsp60, in normal SMG and its tumors. We present illustrative results obtained with immunohistochemistry (IHC) and immunofluorescence-confocal microscopy (IF-CM), which we propose as a platform onto which a data base could be built by adding new information and which would provide material for developing guidelines for tumor identification and monitoring. The initial findings are encouraging in as much as the tumors surveyed showed quantitative patterns of Hsp27 and Hsp60 that distinguished tumoral from normal tissue and certain tumors from the others, and the results from IHC were confirmed by IF-CM.


Subject(s)
Biomarkers, Tumor/metabolism , Carcinogenesis , Chaperonin 60/metabolism , Heat-Shock Proteins/metabolism , Mitochondrial Proteins/metabolism , Molecular Chaperones/metabolism , Neoplasm Proteins/metabolism , Submandibular Gland Neoplasms , Submandibular Gland , Carcinogenesis/metabolism , Carcinogenesis/pathology , Diagnosis, Differential , Female , Humans , Male , Submandibular Gland/metabolism , Submandibular Gland/pathology , Submandibular Gland Neoplasms/diagnosis , Submandibular Gland Neoplasms/metabolism , Submandibular Gland Neoplasms/pathology
8.
Int J Surg Case Rep ; 77S: S147-S151, 2020.
Article in English | MEDLINE | ID: mdl-33191188

ABSTRACT

INTRODUCTION: Burkitt's lymphoma (BL), an aggressive subtype of non-Hodgkin lymphoma (NHL), is extremely rare during pregnancy. In the case of bowel localization, diagnosis can be very difficult. Moreover, signs and symptoms of the primary small intestine lymphoma are nonspecific, mostly attributable to the "mass effect" of the tumor. The most frequent symptom is abdominal cramp-like pain, associated with nausea and vomiting. PRESENTATION OF CASE: We report a rare case of a 37-year-old pregnant woman, at the 33rd week of gestation, with an abdominal-pelvic mass of uncertain nature. Surgical strategy consisted of a two-step procedure, which involved a cesarean section and typing of the mass: extemporaneous examination hypothesized intestinal lymphoma. The definitive histological examination confirmed the diagnosis of rare case of BL in pregnancy. DISCUSSION: The clinical case reported, representing a rare occurrence of BL in pregnancy, was associated with difficult interpretation and complex management. Lymphoma of the small intestine is often overlooked in the early stages of the disease, due to the fact that symptoms are non-specific and consequently underestimated. In our case, based on gestational age, it was possible to perform a multidisciplinary approach, a cesarean section with surgical intestinal exploration, achieving at the same time delivery of the child and a definitive diagnosis of BL with intestinal involvement. CONCLUSION: The involvement of multiple professionals is undoubtedly the best way to deal with the above referred to situation, with the main point being to keep in mind the possibility of this type of occurrence.

9.
Preprint in English | medRxiv | ID: ppmedrxiv-20134577

ABSTRACT

The COVID-19 pandemic has caused a global health crisis. The difficulty to control the viral spread due to the absence of vaccines and prophylactics measures has raised concerns about prevention and control of SARS-CoV-2. Therefore, it becomes more and more crucial the reduction of environmental risk factors through viral inactivation of aerosols and fomites. Photodynamic inactivation of microorganisms by light energy emitted in the visible spectrum region (VIS), not harmful for mammalian cells and safe for humans, has recently been described. A LED-device emitting a special combination of frequencies in the visible light spectrum was tested on SARS-CoV-2 infected cell surnatant dilutions in order to evaluate the antiviral efficacy. This preliminary in vitro study showed for the first time the ability to inactivate SARS-CoV-2 through LED irradiation of visible spectrum wavelengths. If further and more extensive studies will confirm these data, the usage of this LED could potentially have a big impact on the sanitization of virtually all human environments.

10.
J Mol Histol ; 51(2): 109-115, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32300923

ABSTRACT

The salivary glands are key components of the mouth and play a central role in its physiology. Their importance may be appreciated considering their number, occurrence in pairs, and distribution in the mouth: two parotids, two submandibular, two sublingual, and many other small ones scattered throughout the mouth. They produce saliva, without which ingestion of non-liquid nutrients and speech would be practically impossible. Nevertheless, the physiology and pathology of salivary glands are poorly understood. For instance, tumors of salivary glands occur, and their incidence is on the rise, but their etiology and pathogenesis are virtually unknown, although some risk factors have been identified. Likewise, the role of the chaperoning system in the development, normal functioning, and pathology, including carcinogenesis, remains to be determined. This scarcity of basic knowledge impedes progress in diagnosis, disease monitoring, and therapeutics of salivary gland tumors. We are currently involved in examining the chaperoning system of human salivary glands and we performed a search of the literature to determine what has been reported relating to oncology. We found data pertaining to six components of the chaperone system, namely HSP27, HSP60, HSP70, HSP84, HSP86, and GRP78, and to another HSP, the heme-oxygenase H-O1, also named HSP32, which does not belong in the chaperoning system but seemed to have potential as a biomarker for diagnostic purposes as much as the HSP/chaperones mentioned above. The reported quantitative variations of the six chaperones were distinctive enough to distinguish malignant from benign tumors, suggesting that these molecules hold potential as biomarkers useful in differential diagnosis. Also, the quantitative variations described accompanying tumor development, as observed in cancers of other organs, encourages research to elucidate whether chaperones play a role in the initiation and/or progression of salivary gland tumors.


Subject(s)
Molecular Chaperones/metabolism , Salivary Gland Neoplasms/etiology , Salivary Gland Neoplasms/metabolism , Animals , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Disease Susceptibility , Endoplasmic Reticulum Chaperone BiP , Humans , Molecular Chaperones/genetics , Salivary Gland Neoplasms/epidemiology , Salivary Gland Neoplasms/pathology
11.
Clin J Gastroenterol ; 13(3): 377-381, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31728918

ABSTRACT

JC virus is a member of the Polyomavirus family, infects humans worldwide, and 90% of the population carry antibodies to the virus by adult life. The initial infection is asymptomatic, but it may become persistent. JC virus DNA is frequently present in the upper and lower gastrointestinal tracts of healthy adults. Chronic idiopathic intestinal pseudo-obstruction, one of the most severe gastrointestinal motility disorders, is a condition characterized by a clinical picture mimicking small bowel occlusion with related symptoms and signs in the absence of demonstrable mechanical obstruction. Because of the known neuropathic capability of this virus, and its frequent presence in the gut, it has been proposed that JCV might be detectable in tissues of patients with chronic idiopathic intestinal pseudo-obstruction, and possibly be involved in the pathogenesis of this disease, because the virus may actively infect the enteroglial cells of the myenteric plexuses of the patients with chronic idiopathic intestinal pseudo-obstruction. We report two cases of upper idiopathic intestinal pseudo-obstruction associated with JCV infection.


Subject(s)
Duodenal Diseases/etiology , Intestinal Pseudo-Obstruction/etiology , JC Virus , Polyomavirus Infections/complications , Tumor Virus Infections/complications , Duodenal Diseases/diagnosis , Duodenal Diseases/pathology , Duodenal Diseases/virology , Duodenoscopy , Female , Humans , Intestinal Pseudo-Obstruction/diagnosis , Intestinal Pseudo-Obstruction/pathology , Intestinal Pseudo-Obstruction/virology , Male , Middle Aged , Polyomavirus Infections/virology , Tumor Virus Infections/virology
12.
Case Rep Dent ; 2018: 9261276, 2018.
Article in English | MEDLINE | ID: mdl-29808130

ABSTRACT

The aim of this case report is to describe the surgical and prosthetic procedures to achieve maxillary and mandibular implant-supported PMMA monolithic full-arch rehabilitation (PMFR) with surgical computer-planned guide and immediate provisional. In such cases, the correct planning of dental implants' position, length, and diameter and the prosthetic phases via computer-aided design are very important to achieve good aesthetic and functional long-lasting results.

13.
Article in English | MEDLINE | ID: mdl-27496576

ABSTRACT

Many bone substitutes have been proposed for bone regeneration, and researchers have focused on the interactions occurring between grafts and host tissue, as the biologic response of host tissue is related to the origin of the biomaterial. Bone substitutes used in oral and maxillofacial surgery could be categorized according to their biologic origin and source as autologous bone graft when obtained from the same individual receiving the graft; homologous bone graft, or allograft, when harvested from an individual other than the one receiving the graft; animal-derived heterologous bone graft, or xenograft, when derived from a species other than human; and alloplastic graft, made of bone substitute of synthetic origin. The aim of this review is to describe the most commonly used bone substitutes, according to their origin, and to focus on the biologic events that ultimately lead to the integration of a biomaterial with the host tissue.


Subject(s)
Biocompatible Materials/pharmacology , Bone Regeneration/physiology , Bone Substitutes/pharmacology , Oral Surgical Procedures , Osseointegration/physiology , Humans
14.
J Clin Pharmacol ; 56(9): 1094-103, 2016 09.
Article in English | MEDLINE | ID: mdl-26785826

ABSTRACT

Despite wide clinical experience with deferiprone, the optimum dosage in children younger than 6 years remains to be established. This analysis aimed to optimize the design of a prospective clinical study for the evaluation of deferiprone pharmacokinetics in children. A 1-compartment model with first-order oral absorption was used for the purposes of the analysis. Different sampling schemes were evaluated under the assumption of a constrained population size. A sampling scheme with 5 samples per subject was found to be sufficient to ensure accurate characterization of the pharmacokinetics of deferiprone. Whereas the accuracy of parameters estimates was high, precision was slightly reduced because of the small sample size (CV% >30% for Vd/F and KA). Mean AUC ± SD was found to be 33.4 ± 19.2 and 35.6 ± 20.2 mg · h/mL, and mean Cmax ± SD was found to be 10.2 ± 6.1 and 10.9 ± 6.7 mg/L based on sparse and frequent sampling, respectively. The results showed that typical frequent sampling schemes and sample sizes do not warrant accurate model and parameter identifiability. Expectation of the determinant (ED) optimality and simulation-based optimization concepts can be used to support pharmacokinetic bridging studies. Of importance is the accurate estimation of the magnitude of the covariate effects, as they partly determine the dose recommendation for the population of interest.


Subject(s)
Iron Chelating Agents/pharmacokinetics , Iron Chelating Agents/therapeutic use , Pyridones/pharmacokinetics , Pyridones/therapeutic use , beta-Thalassemia/drug therapy , beta-Thalassemia/metabolism , Child , Child, Preschool , Deferiprone , Humans , Infant , Infant, Newborn , Prospective Studies
15.
Article in English | MEDLINE | ID: mdl-26697558

ABSTRACT

Invasive cervical resorption (ICR) lesion is an aggressive form of tooth destruction that usually begins immediately below the epithelial attachment. It has been described as a purely inflammatory reaction that can be started by microorganism infection, or an aseptic resorptive process that can be secondarily infected. The potential etiologic and predisposing factors for ICR are orthodontic treatment, traumatic injuries, bleaching, periodontal therapy, and idiopathic factors. This case series with a 3-year follow-up shows that Class 2 ICR lesions have a good prognosis in 100% of cases. Class 3 ICR lesions should be considered at risk. However, in the authors' experience, the treatment of Class 3 ICR lesions is compatible with tooth maintenance.


Subject(s)
Dental Restoration, Permanent/methods , Root Resorption/diagnosis , Root Resorption/surgery , Adult , Debridement , Female , Follow-Up Studies , Humans , Male , Prognosis , Risk Factors , Root Resorption/etiology , Surgical Flaps
16.
Case Rep Dent ; 2015: 437412, 2015.
Article in English | MEDLINE | ID: mdl-26609452

ABSTRACT

The aim of this case report was to describe the surgical sequence of crown lengthening to apically reposition the dentogingival complex, in addition to an esthetic restorative procedure. Many different causes can be responsible for short clinical crown. In these cases, the correct execution of a restorative or prosthetic rehabilitation requires an increasing of the crown length. According to the 2003 American Academy of Periodontology (Practice Profile Survey), crown lengthening is the most habitual surgical periodontal treatment.

17.
J Craniofac Surg ; 26(3): 741-4, 2015 May.
Article in English | MEDLINE | ID: mdl-25974783

ABSTRACT

BACKGROUND: The aim of this work is to evaluate differences occurring in bone tissue around dental implants positioned using piezoelectric or conventional drill technique. METHODS: Twenty-four implants were inserted bilaterally in the iliac crest of 6 sheep after site preparation through a piezoelectric instrument (Test) or after site preparation through conventional drill technique with rotary instruments (Control). Animals were randomly divided to be euthanized at 15 and 30 days post-intervention (p.i.); peri-implant bone samples were withdrawn and processed for histological analysis and immunohistochemical evaluation of iNOS and Bax expression. RESULTS: Active remodeling phenomena in both Test and Control samples are showed at 15 days p.i., while at 30 days p.i., the overall organization of the peri-implant bone resembles native bone tissue. Immunohistochemical evaluation reveals a statistically significant increase of both iNOS and Bax expression at 15 days p.i. compared to samples obtained 30 days p.i. and to native bone. At both healing times, a higher but not statistically significant iNOS and Bax expression is recorded in samples from Control compared to Test Group. CONCLUSION: Even if the insertion protocol does not seem to significantly interfere with the long-term healing process, implant site preparation through the piezoelectric bone surgery technique may allow a reduction of peri-implant bone tissue inflammation and support a more rapid bone tissue healing phase.


Subject(s)
Bone-Implant Interface/pathology , Dental Implantation, Endosseous/methods , Dental Instruments , Nitric Oxide Synthase Type II/analysis , Osseointegration/physiology , Piezosurgery/methods , bcl-2-Associated X Protein/analysis , Animals , Models, Animal , Random Allocation , Sheep
18.
Implant Dent ; 24(4): 377-83, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25915409

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate in vitro the behavior and the biocompatibility of primary human osteoblasts (HOs) grown onto different implant surface. METHODS AND MATERIALS: HOs were cultured onto sandblasted/acid-etched (control group) and sandblasted/acid-etched followed by coating with inorganic ions (test group) experimental titanium discs. At established times, SEM analysis, LDH assay, MTT assay, and enzyme-linked immunosorbent assay for type 1 collagen, interleukin (IL)-6, and PGE2 secretion were performed. RESULTS: Both surfaces promote HOs adhesion and proliferation. After 21 days, cells on test surfaces are well spread, flattened, and attached by cellular extensions, whereas cells on control discs appear mainly elongated. Lower LDH levels and higher values of MTT assay are recorded for cells on test respect to control surfaces at each experimental time. Type 1 collagen release increases until 14 days, significantly decreasing at day 21 in cells grown on both surfaces. IL-6 and PGE2 secretion shows a peak in control group samples at day 7, whereas their levels do not significantly modify in both groups at days 14 and 21. CONCLUSION: Results indicate that the test group surface is more biocompatible, well tolerated, and suitable for supporting osteoblasts growth and proliferation.


Subject(s)
Dental Implantation, Endosseous/methods , Dental Implants , Osseointegration/physiology , Osteoblasts/cytology , Surface Properties , Alkaline Phosphatase/biosynthesis , Biocompatible Materials , Cell Adhesion , Cell Differentiation , Cell Proliferation , Cells, Cultured , Collagen Type I/biosynthesis , Dinoprostone/metabolism , Humans , Interleukin-6/biosynthesis , Titanium/chemistry
19.
Clin Oral Investig ; 19(3): 601-11, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25055744

ABSTRACT

OBJECTIVE: This study aimed to check the effect of zoledronic acid (ZA) at subtoxic dose on human osteoblasts (HOs) in terms of cell viability, apoptosis occurrence, and differentiation induction. ZA belongs to the family of bisphosphonates (BPs), largely used in the clinical practice for the treatment of bone diseases, often associated with jaw osteonecrosis onset. Their pharmacological action consists in the direct block of the osteoclast-mediated bone resorption along with indirect action on osteoblasts. MATERIALS AND METHODS: HOs were treated choosing the highest limit concentration (10(-5) M) which does not induce toxic effects. Live/dead staining, flow cytometry, mitochondrial membrane potential assay, osteocalcin western blotting, gp38 RT-PCR, collagen type I, PGE2, and IL-6 ELISA assays were performed. RESULTS: Similar viability level between control and ZA-treated samples is found along with no significant increase of apoptotic and necrotic cells in ZA-treated sample. To establish if an early apoptotic pathway was triggered, Bax expression and mitochondrial membrane potential were evaluated finding a higher protein expression in control sample and a good integrity of mitochondrial membrane in both experimental points. Type I collagen secretion and alkaline phosphatase (ALP) activity appear increased in ZA-treated sample, osteocalcin expression level is reduced in ZA-treated cells, whereas no modifications of gp38 mRNA level are evidenced. No statistical differences are identified in PGE2 secretion level whereas IL-6 secretion is lower in ZA-treated HOs with respect to control ones. CONCLUSIONS: These results highlight that ZA, delaying the osteoblastic differentiation process versus the osteocytic lineage, strengthens its pharmacological activity enhancing bone density. CLINICAL RELEVANCE: The knowledge of ZA effects on osteoblasts at subtoxic dose allows to improve therapeutic protocols in order to strengthen drug pharmacological activity through a combined action on both osteoclastic and osteoblastic cells.


Subject(s)
Bone Density Conservation Agents/pharmacology , Diphosphonates/pharmacology , Imidazoles/pharmacology , Osteoblasts/drug effects , Aged , Aged, 80 and over , Apoptosis/drug effects , Blotting, Western , Bone Density/drug effects , Cell Differentiation/drug effects , Cell Survival/drug effects , Collagen Type I/metabolism , Dinoprostone/metabolism , Enzyme-Linked Immunosorbent Assay , Humans , In Vitro Techniques , Interleukin-6/metabolism , Membrane Potential, Mitochondrial , Real-Time Polymerase Chain Reaction , Zoledronic Acid
20.
Clin Oral Investig ; 19(6): 1269-77, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25352469

ABSTRACT

OBJECTIVES: The aim of our work was to evaluate the role of nitric oxide (NO) in the in vitro response of human gingival fibroblasts (HGFs) to 1, 5, 10, and 100 µM doses of zoledronic acid (ZA), a bisphosphonate largely used in the clinical practice and for which several adverse effects are reported. MATERIALS AND METHODS: Phase contrast microscopy and live/dead staining were used to evaluate HGFs morphology; cell viability, collagen type I and interleukin 6 (IL-6) secretion were evaluated by 3-[4,5-dimethyl-thiazol-2-yl-]-2,5-diphenyl tetrazolium bromide (MTT) and enzyme-linked immunosorbent assay (ELISA) assays. Reactive oxygen species (ROS) production and mitochondrial membrane potential were evaluated by flow cytometry; NO production and NOS activity by spectrophotometric analysis; endothelial NOS (eNOS) and neuronal NOS (nNOS) expression by immunofluorescence. RESULTS: Viable fibroblasts are evidenced in control sample while floating dead cells and cells close to detachment phase in ZA-treated sample, in agreement with decreased level of collagen type I. Control sample shows higher number of viable cells respect to ZA-treated one and ROS production increases when ZA is added. Released NO in ZA-treated sample appears higher and NO overproduction is related to increased nNOS activity. IL-6 secretion level is higher in ZA-treated sample than in control one. CONCLUSIONS: Our results suggest ROS involvement in NO overproduction, due to nNOS recruitment, both at low and high doses. In turn, NO release seems to be able to trigger the inflammatory response only when high doses are administered, thus confirming the ZA cytotoxic effect on HGFs. CLINICAL RELEVANCE: The knowledge of ZA-mediated cytotoxicity mechanisms on HGFs allows to better understand drug pharmacological activity.


Subject(s)
Bone Density Conservation Agents/pharmacology , Diphosphonates/pharmacology , Fibroblasts/drug effects , Gingiva/cytology , Imidazoles/pharmacology , Nitric Oxide/physiology , Adult , Cell Survival/drug effects , Collagen Type I/metabolism , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Fluorescent Antibody Technique , Humans , Interleukin-6/metabolism , Zoledronic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...